Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 14 studies | 26% ± 10% | |
fibroblast | 14 studies | 32% ± 12% | |
oligodendrocyte precursor cell | 10 studies | 32% ± 15% | |
basal cell | 10 studies | 32% ± 19% | |
astrocyte | 10 studies | 28% ± 8% | |
microglial cell | 9 studies | 28% ± 5% | |
epithelial cell | 9 studies | 37% ± 18% | |
ciliated cell | 9 studies | 21% ± 5% | |
B cell | 8 studies | 24% ± 8% | |
adipocyte | 8 studies | 27% ± 8% | |
secretory cell | 6 studies | 32% ± 12% | |
club cell | 6 studies | 19% ± 3% | |
pericyte | 6 studies | 26% ± 15% | |
respiratory goblet cell | 5 studies | 34% ± 10% | |
glutamatergic neuron | 5 studies | 36% ± 19% | |
type I pneumocyte | 5 studies | 31% ± 12% | |
smooth muscle cell | 5 studies | 23% ± 9% | |
retinal pigment epithelial cell | 4 studies | 40% ± 21% | |
naive B cell | 4 studies | 17% ± 1% | |
luminal cell of prostate epithelium | 4 studies | 27% ± 8% | |
classical monocyte | 3 studies | 22% ± 5% | |
conventional dendritic cell | 3 studies | 23% ± 7% | |
non-classical monocyte | 3 studies | 23% ± 6% | |
macrophage | 3 studies | 27% ± 2% | |
squamous epithelial cell | 3 studies | 35% ± 21% | |
CD4-positive, alpha-beta T cell | 3 studies | 24% ± 4% | |
effector memory CD8-positive, alpha-beta T cell | 3 studies | 21% ± 2% | |
mesothelial cell | 3 studies | 23% ± 3% | |
endothelial cell of vascular tree | 3 studies | 21% ± 7% | |
cholangiocyte | 3 studies | 49% ± 24% | |
hepatocyte | 3 studies | 50% ± 25% | |
CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
connective tissue cell | 3 studies | 30% ± 6% | |
adventitial cell | 3 studies | 26% ± 7% | |
monocyte | 3 studies | 20% ± 3% | |
natural killer cell | 3 studies | 19% ± 4% | |
lymphocyte | 3 studies | 31% ± 5% | |
muscle cell | 3 studies | 27% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6519.87 | 1445 / 1445 | 100% | 55.53 | 183 / 183 |
thymus | 100% | 10148.28 | 653 / 653 | 99% | 42.73 | 600 / 605 |
kidney | 100% | 6582.91 | 89 / 89 | 99% | 30.85 | 893 / 901 |
lung | 100% | 6473.82 | 577 / 578 | 99% | 36.67 | 1146 / 1155 |
pancreas | 100% | 3170.57 | 328 / 328 | 99% | 47.46 | 176 / 178 |
stomach | 100% | 3784.67 | 359 / 359 | 98% | 25.76 | 281 / 286 |
bladder | 100% | 8418.86 | 21 / 21 | 98% | 39.48 | 494 / 504 |
prostate | 100% | 7984.56 | 245 / 245 | 98% | 18.41 | 491 / 502 |
uterus | 100% | 7676.89 | 170 / 170 | 98% | 42.87 | 448 / 459 |
intestine | 100% | 4970.56 | 966 / 966 | 98% | 23.21 | 514 / 527 |
breast | 100% | 6991.82 | 459 / 459 | 97% | 25.76 | 1082 / 1118 |
skin | 100% | 7326.42 | 1809 / 1809 | 95% | 18.89 | 447 / 472 |
ovary | 100% | 8121.72 | 180 / 180 | 92% | 16.89 | 396 / 430 |
liver | 100% | 3081.88 | 226 / 226 | 88% | 19.06 | 358 / 406 |
brain | 83% | 2527.84 | 2204 / 2642 | 99% | 26.36 | 699 / 705 |
adrenal gland | 89% | 1685.41 | 229 / 258 | 57% | 7.37 | 131 / 230 |
adipose | 100% | 8758.18 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 4804.14 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 71.31 | 1 / 1 |
muscle | 100% | 8132.32 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5925.39 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 4541.18 | 849 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 45.95 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 94% | 14.16 | 75 / 80 |
lymph node | 0% | 0 | 0 / 0 | 69% | 9.48 | 20 / 29 |
peripheral blood | 53% | 1897.40 | 496 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0017015 | Biological process | regulation of transforming growth factor beta receptor signaling pathway |
GO_0007254 | Biological process | JNK cascade |
GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
GO_0008283 | Biological process | cell population proliferation |
GO_0033689 | Biological process | negative regulation of osteoblast proliferation |
GO_0001947 | Biological process | heart looping |
GO_0030878 | Biological process | thyroid gland development |
GO_0023019 | Biological process | signal transduction involved in regulation of gene expression |
GO_0006955 | Biological process | immune response |
GO_0060395 | Biological process | SMAD protein signal transduction |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0001707 | Biological process | mesoderm formation |
GO_0050821 | Biological process | protein stabilization |
GO_0001666 | Biological process | response to hypoxia |
GO_1902895 | Biological process | positive regulation of miRNA transcription |
GO_0048701 | Biological process | embryonic cranial skeleton morphogenesis |
GO_0048589 | Biological process | developmental growth |
GO_0050927 | Biological process | positive regulation of positive chemotaxis |
GO_0070306 | Biological process | lens fiber cell differentiation |
GO_0032909 | Biological process | regulation of transforming growth factor beta2 production |
GO_0042110 | Biological process | T cell activation |
GO_0042177 | Biological process | negative regulation of protein catabolic process |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0001657 | Biological process | ureteric bud development |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0061767 | Biological process | negative regulation of lung blood pressure |
GO_0001701 | Biological process | in utero embryonic development |
GO_0061045 | Biological process | negative regulation of wound healing |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_1902894 | Biological process | negative regulation of miRNA transcription |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0042307 | Biological process | positive regulation of protein import into nucleus |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0045216 | Biological process | cell-cell junction organization |
GO_0042060 | Biological process | wound healing |
GO_0032916 | Biological process | positive regulation of transforming growth factor beta3 production |
GO_1901203 | Biological process | positive regulation of extracellular matrix assembly |
GO_0030325 | Biological process | adrenal gland development |
GO_0045429 | Biological process | positive regulation of nitric oxide biosynthetic process |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0048340 | Biological process | paraxial mesoderm morphogenesis |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0048617 | Biological process | embryonic foregut morphogenesis |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0051496 | Biological process | positive regulation of stress fiber assembly |
GO_0032332 | Biological process | positive regulation of chondrocyte differentiation |
GO_0001889 | Biological process | liver development |
GO_0050776 | Biological process | regulation of immune response |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0007492 | Biological process | endoderm development |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0050678 | Biological process | regulation of epithelial cell proliferation |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0051894 | Biological process | positive regulation of focal adhesion assembly |
GO_0001756 | Biological process | somitogenesis |
GO_0038092 | Biological process | nodal signaling pathway |
GO_0016202 | Biological process | regulation of striated muscle tissue development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_1903243 | Biological process | negative regulation of cardiac muscle hypertrophy in response to stress |
GO_0032924 | Biological process | activin receptor signaling pathway |
GO_0060039 | Biological process | pericardium development |
GO_1902893 | Biological process | regulation of miRNA transcription |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0002520 | Biological process | immune system development |
GO_0098586 | Biological process | cellular response to virus |
GO_0009880 | Biological process | embryonic pattern specification |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0030154 | Biological process | cell differentiation |
GO_0010718 | Biological process | positive regulation of epithelial to mesenchymal transition |
GO_0060290 | Biological process | transdifferentiation |
GO_0002076 | Biological process | osteoblast development |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0030501 | Biological process | positive regulation of bone mineralization |
GO_1990776 | Biological process | response to angiotensin |
GO_0051481 | Biological process | negative regulation of cytosolic calcium ion concentration |
GO_0031053 | Biological process | primary miRNA processing |
GO_0005634 | Cellular component | nucleus |
GO_0071141 | Cellular component | SMAD protein complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005637 | Cellular component | nuclear inner membrane |
GO_0005829 | Cellular component | cytosol |
GO_0071144 | Cellular component | heteromeric SMAD protein complex |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0001222 | Molecular function | transcription corepressor binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0001223 | Molecular function | transcription coactivator binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0070410 | Molecular function | co-SMAD binding |
GO_0019902 | Molecular function | phosphatase binding |
GO_0017151 | Molecular function | DEAD/H-box RNA helicase binding |
GO_0001217 | Molecular function | DNA-binding transcription repressor activity |
GO_0005518 | Molecular function | collagen binding |
GO_0043130 | Molecular function | ubiquitin binding |
GO_0035259 | Molecular function | nuclear glucocorticoid receptor binding |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0003677 | Molecular function | DNA binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0070412 | Molecular function | R-SMAD binding |
GO_0016922 | Molecular function | nuclear receptor binding |
GO_0043425 | Molecular function | bHLH transcription factor binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0031962 | Molecular function | nuclear mineralocorticoid receptor binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0008013 | Molecular function | beta-catenin binding |
GO_0032810 | Molecular function | sterol response element binding |
GO_0070411 | Molecular function | I-SMAD binding |
GO_0005160 | Molecular function | transforming growth factor beta receptor binding |
Gene name | SMAD3 |
Protein name | Mothers against decapentaplegic homolog (MAD homolog) (Mothers against DPP homolog) (SMAD family member) SMAD family member 3 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) |
Synonyms | MADH3 |
Description | FUNCTION: Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD3/SMAD4 complex, activates transcription. Also can form a SMAD3/SMAD4/JUN/FOS complex at the AP-1/SMAD site to regulate TGF-beta-mediated transcription. Has an inhibitory effect on wound healing probably by modulating both growth and migration of primary keratinocytes and by altering the TGF-mediated chemotaxis of monocytes. This effect on wound healing appears to be hormone-sensitive. Regulator of chondrogenesis and osteogenesis and inhibits early healing of bone fractures. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator. . |
Accessions | ENST00000540846.6 [P84022-3] ENST00000537194.6 [P84022-4] ENST00000558739.1 ENST00000681239.1 [P84022-3] ENST00000558739.2 [P84022-3] H3BVD1 ENST00000558894.5 H0YKE2 ENST00000679624.1 [P84022-3] ENST00000558428.5 ENST00000560424.2 H0YNV1 ENST00000558827.2 [P84022-4] H0YMP2 ENST00000558827.1 P84022 ENST00000559460.6 [P84022-3] H3BQ00 ENST00000559092.1 ENST00000559460.5 ENST00000560175.5 H3BP09 H0YMY0 ENST00000327367.9 [P84022-1] ENST00000439724.7 [P84022-2] H0YL71 ENST00000558428.6 [P84022-4] |